Description:
A substance being studied in the treatment of some types of cancer, including Wilms tumor, neuroblastoma, rhabdomyosarcoma, and other types of soft tissue sarcoma. BB-10901 contains a monoclonal antibody that binds to a protein called CD56 on some types of cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells after BB-10901 binds to them. BB-10901 is a type of antibody-drug conjugate. Also called lorvotuzumab mertansine.
